(EFA) MSCI EAFE - Overview
Etf: Stocks, Developed Markets, International, Equity, Large-Mid Cap
Dividends
| Dividend Yield | 3.55% |
| Yield on Cost 5y | 5.04% |
| Yield CAGR 5y | 5.54% |
| Payout Consistency | 92.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.0% |
| Relative Tail Risk | 2.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.53 |
| Alpha | 20.90 |
| Character TTM | |
|---|---|
| Beta | 0.682 |
| Beta Downside | 0.642 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.05% |
| CAGR/Max DD | 1.22 |
Description: EFA MSCI EAFE January 27, 2026
The iShares MSCI EAFE ETF (NYSE ARCA:EFA) seeks to track the MSCI EAFE Index by investing at least 80 % of its net assets in the index’s constituent securities or in securities that are economically equivalent, delivering exposure to large- and mid-cap equities across developed markets outside the United States and Canada.
As of January 2026, the fund holds roughly $75 billion in assets, charges an expense ratio of 0.32 %, and its top five holdings are Nestlé (SWISS), Roche (SWISS), ASML (NL), LVMH (FR) and Unilever (UK/NL), together representing about 12 % of the portfolio. Sector allocations are led by Financials (≈ 18 %), Consumer Staples (≈ 15 %), Industrials (≈ 14 %), Health Care (≈ 13 %) and Technology (≈ 10 %). Recent performance has been driven by divergent monetary-policy cycles-Eurozone rate hikes easing inflation expectations while the UK and Japan remain in accommodative stances-plus a modest rebound in European industrial output, which together have supported a YTD total-return of roughly 5 %.
For a deeper, data-rich analysis of EFA’s valuation and risk profile, you may want to explore the fund’s metrics on ValueRay.
What is the price of EFA shares?
Over the past week, the price has changed by +1.19%, over one month by +4.77%, over three months by +9.63% and over the past year by +32.60%.
Is EFA a buy, sell or hold?
What are the forecasts/targets for the EFA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 122.8 | 19.6% |
EFA Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 73.83b USD (73.83b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 73.83b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 73.83b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.43% (E(73.83b)/V(73.83b) * Re(8.43%) + (debt-free company))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)